|
|
|
|


* Comparative Animal Nutrition Laboratory, Department of Small Animal Clinical Sciences, College of Veterinary Medicine and Faculty of Nutrition, Texas A&M University, College Station, TX, USA and
Kao Corporation, Tokyo, Japan
4 To whom correspondence should be addressed. E-mail: jbauer{at}cvm.tamu.edu.
KEY WORDS: diacylglycerol glycemic index postprandial insulin lipids dogs
Digestion and assimilation of dietary fatty acids is a complex postprandial process involving triacylglycerol (TAG)5 hydrolysis, fatty acid absorption, resynthesis of TAG in intestinal mucosal cells, and chylomicron secretion. Dietary vegetable oils contain tri-, di-, and monoacylglycerols, although most edible oils contain approximately 8798% of their acylglycerols as TAG, whereas diacylglycerols (DAG) comprise 0.89.5%. DAG is a glycerol with 2 acyl groups esterified to sn-1 and sn-2 (1,2-DAG) or sn-1 and sn-3 (1,3-DAG) positions (1). Canola oil contains 0.8% DAG, corn oil 2.8%, olive oil 5.5%, and cottonseed oil 9.5%. Oils enriched in DAG have recently become available and have recently been studied in several species. These oils contain >80% DAG of which 70% is 1,3-DAG, <20% TAG, <3% monoacylglycerol (MAG), and small amounts of antioxidants. Both 1,2-DAG and MAG are digestive intermediates of TAG, which are transiently generated in intestinal mucosal cells of the digestive tract.
Emulsions containing either DAG- or TAG-enriched oils were administered to rats, resulting in smaller TAG postprandial concentrations (2). Rats fed DAG-containing diets for 4 wk showed less weight gain than those on a TAG diet (3). In humans, weight reduction was observed when DAG replaced a part of dietary fat (4). Various mechanisms for potential antiobesity effects of DAG have been proposed (5,6). Cellular utilization of the 1,3-DAG results in different metabolic effects compared with TAG, and studies to date support the hypothesis that DAG oil increases fat oxidation in the liver or small intestine, thus limiting dietary fatty acid conversion to adipose tissue triglyceride. This effect may play a role in long-term weight management or reduction (47).
Little information is available on the effect of DAG-enriched oils on canine lipid metabolism. The present study was undertaken to provide comparative information in dogs regarding the postprandial effects of meals enriched in DAG vs. TAG oil on lipid, lipase, and carbohydrate metabolism. In addition, carbohydrate type was investigated by incorporating high- or low-glycemic-index carbohydrates in test meals used.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Statistical analysis
Data are expressed as means + SEM. The effects of diet and time on postprandial plasma changes were evaluated via repeated-measures ANOVA, and significance was set at P < 0.05 or as noted. Where appropriate, multiple comparisons for main effects of diet, time, and diet x time interactions were performed at P < 0.05 (Statistix 7.0; Analytical Software). Where there was a significant interaction of group and time, contrasts were made using 1-way ANOVA followed by LSD tests to determine where the difference occurred. An experiment-wide type I error of 0.05 was maintained. All data were found to follow a normal distribution at P < 0.05 using the Shapiro-Wilk test. If variances were nonhomogeneous, log10 transformed data were analyzed.
| RESULTS |
|---|
|
|
|---|
|
|
|
|
| DISCUSSION |
|---|
|
|
|---|
Marked differences in insulin response found after feeding the HGI starch meal were not unexpected. No modification of this response was observed with dietary oil type. Thus, starch type has a dramatic effect on insulin responsiveness to meal feeding, whether or not DAG or TAG is present. It is noteworthy, however, that no differences in plasma glucose concentration were seen in any group other than the expected postprandial effect. Elevated circulating insulin concentrations would be expected to increase cellular glucose uptake. This finding suggests that more glucose was being made available from either glycogen or, more likely, other sources to maintain steady plasma concentrations.
The significant elevation of plasma NEFA with the LGI meals is also of interest. If glucose flux into cells had been decreased in the LGI groups as a result of an attenuated insulin response, then relatively more tissue lipolysis from storage sites would be favored, resulting in fatty acid mobilization and the NEFA elevations observed. It is well known that decreased insulin levels promote hormone-sensitive lipase activity and lipolysis (11). A less potent release of insulin with LGI starch might also result in less active utilization of circulating NEFA. Alternatively, increased intravascular lipolysis in response to the relative high fat content of the test meals may have occurred also, resulting in higher plasma NEFA. Taken together, these findings would favor adipogenesis overall with HGI starch compared with LGI starch resulting in greater risk of obesity. Data in rats have suggested that digestion and absorption of a LGI starch may be slower than HGI starch, leading to reduced lipogensis in adipose and liver tissues (12), whereas the apparent digestibility of LGI starch is similar to that of normal cornstarch (13). Canine studies have yet to be done on these particular questions.
Finally, HL and LPL activities were not different among the groups, although a tendency for higher HL values was seen when LGI starch was fed. It is unknown what effect diets containing DAG oil or LGI vs. HGI starches might have when fed for longer periods. Increased HL activities after feeding such diets, should they occur, would be consistent with increased HL-mediated high-density lipoprotein-bound TG lipolysis or cholesteryl ester uptake by the liver and also promote postprandial plasma triglyceride lowering (14). It is unknown at this time whether this may occur.
| FOOTNOTES |
|---|
2 Author disclosure: Lodging expenses at the symposium for the corresponding author were paid by the WALTHAM Centre for Nutrition. ![]()
3 Supported by Kao Corporation and the Mark L. Morris Professorship in Clinical Nutrition, Texas A&M University. ![]()
5 Abbreviations used: ß-HB, ß-hydroxyburyrate; DAG, diacylglycerol; EDTA, ethylenediaminetetraacetate; GI, glycemic index; HGI, high glycemic index; HL, hepatic lipase; LGI, low glycemic index; LPL, lipoprotein lipase; MAG, monoacylglycerol; NEFA, nonesterifed fatty acid; TAG, triacylglycerol. ![]()
| LITERATURE CITED |
|---|
|
|
|---|
1. Yasukawa T, Katsuragi Y. Diacylglycerols. In: Katsuragi Y, Yasukawa T, Matsuo N, Flickinger BD, Toimitsu I, Matlok MG, editors. Diacylglycerol oil. Champaign: American Oil Chemists' Society; 2004. p. 115.
2. Murata M, Hara K, Ide T. Alteration by diacylglycerols of the transport and fatty acid composition of lymph chylomicrons in rats. Biosci Biotechnol Biochem. 1994;58:14169.
3. Murata M, Ide T, Hara K. Reciprocal responses to dietary diacylglycerol of hepatic enzymes of fatty acid synthesis and oxidation in the rat. Br J Nutr. 1997;77:10721.[Medline]
4. Nagao T, Watanabe H, Goto N, Onizawa K, Taguchi H, Matsuo N, Yasukawa T, Tsushima R, Shimasaki H, Itakura H. Dietary diacylglycerol suppresses accumulation of body fat compared to triacylglycerol in men in a double-blind controlled trial. J Nutr. 2000;130:7927.
5. Maki KC, Davidson MH, Tsushima R, Matsuo N, Tokimitsu I, Umporowicz DM, Dicklin MR, Foster GS, Ingram KA, et al. Consumption of diacylglycerol oil as part of a reduced energy diet enhances loss of body weight and fat in compared to triacylglycerol control oil. Am J Clin Nutr. 2002;76:12306.
6. Flicklinger BD. The effect of diacylglycerols on energy expenditure and substrate utilization in humans. In: Katsuragi Y, Yasukawa T, Matsuo N, Flickinger BD, Toimitsu I, Matlok MG, editors. Diacylglycerol oil. Champaign: American Oil Chemists' Society; 2004. p. 5863.
7. Murase T, Aoki M, Wakisaka T, Hase T, Tokimitsu I. Anti-obesity effect of dietary diacylglycerol in C57L/6J Mice: Dietary diacylglycerol stimulates intestinal lipid metabolism. J Lipid Res. 2002;43:13129.
8. Watanabe H, Tokimitsu I. Digestion and absorption of diacylglycerol. In: Katsuragi Y, Yasukawa T, Matsuo N, Flickinger BD, Toimitsu I, Matlok MG, editors. Diacylglycerol oil. Champaign: American Oil Chemists' Society; 2004. p. 3045.
9. Butterwick RF, McConnell M, Markwell PJ, Watson TDG. Influence of age and sex on plasma lipoid and lipoprotein concentrations and associated enzyme activities in cats. Am J Vet Res. 2001;62:3316.[Medline]
10. Umeda T, Bauer JE, Otsuji K. Weight loss effect of dietary diacylglycerol in obese dogs. J Anim Physiol Anim Nutr. 2006; in press.
11. Van Harmelen V, Reynisdottir S, Cianflone K, Degerman E, Hoffstedt J, Nilsel K, Sniderman A, Arner P. 1999. Mechanisms involved in the regulation of free fatty acid release from isolated human fat cells by acylation-stimulating protein and insulin. J Biol Chem. 274:1824351.
12. Goda T, Urakawa T, Watanabe M, Takase S. Effect of high-amylose starch on carbohydrate digestive capacity and lipgenesis in epididymal adipose tissue and liver of rats. 1994. J Nutr Biochem. 5:256260.
13. Kishida T, Nogami H, Himeno S, Ebihare K. Heat moisture treatment of high amylose cornstarch increases it resistant starch content but not is physiologic effect in rats. J Nutr. 2001;131:271621.
14. Nikkila EA, Huttunen JK, Ehnholm C. Postheparin plasma lipoprotein lipase and hepatic lipase in diabetes mellitus. Relationship to plasma triglyceride metabolism. Diabetes. 1977;26:1121.[Abstract]
This article has been cited by other articles:
![]() |
G. Reyes, K. Yasunaga, E. Rothenstein, W. Karmally, R. Ramakrishnan, S. Holleran, and H. N. Ginsberg Effects of a 1,3-diacylglycerol oil-enriched diet on postprandial lipemia in people with insulin resistance J. Lipid Res., March 1, 2008; 49(3): 670 - 678. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||